OpenAI has introduced GPT-Rosalind, a frontier AI model designed to support life sciences research, including biology, drug discovery, and translational medicine. The model is built for scientific workflows, combining advanced reasoning with strong understanding of chemistry, genomics, and protein engineering.
It helps researchers process large volumes of data, generate hypotheses, and plan experiments more efficiently. GPT-Rosalind is available as a research preview through ChatGPT, Codex, and the API for qualified users.
By improving early-stage discovery and decision-making, the model aims to accelerate scientific breakthroughs and reduce the time required to develop new treatments.
